Cholesteryl Butyrate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCholesteryl Butyrate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMelanomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungMelanomaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A